SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-035228
Filing Date
2022-11-04
Accepted
2022-11-04 17:58:08
Documents
1
Period of Report
2022-11-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 21048
  Complete submission text file 0000899243-22-035228.txt   22452
Mailing Address C/O GOOGLE VENTURES 2011, L.P. 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043
Business Address
Yeshwant Krishna (Reporting) CIK: 0001585001 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40489 | Film No.: 221363262

Mailing Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215
Business Address 201 BROOKLINE AVENUE SUITE 601 BOSTON MA 02215 (978) 501-3026
Verve Therapeutics, Inc. (Issuer) CIK: 0001840574 (see all company filings)

IRS No.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations